Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:


Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Drug Price Trends for RIFAMPIN

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Drug Price Trends for RIFAMPIN

Average Pharmacy Cost for RIFAMPIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
RIFAMPIN 300 MG CAPSULE 00527-1315-01 0.58663 EACH 2019-12-18
RIFAMPIN 300 MG CAPSULE 68180-0659-07 0.58663 EACH 2019-12-18
RIFAMPIN 300 MG CAPSULE 00185-0799-05 0.58663 EACH 2019-12-18
RIFAMPIN 300 MG CAPSULE 00185-0799-60 0.58663 EACH 2019-12-18
RIFAMPIN 300 MG CAPSULE 00185-0799-30 0.58663 EACH 2019-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for RIFAMPIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
RIFAMPIN 300MG CAP Major Pharmaceuticals 00904-5282-61 100 65.13 0.65130 EACH 2018-12-01 - 2023-11-30 FSS
RIFAMPIN 150MG CAP Golden State Medical Supply, Inc. 61748-0015-11 1X100 94.83 2018-01-01 - 2022-12-31 FSS
RIFAMPIN 300MG CAP Mylan Institutional, Inc. 51079-0890-20 100UD 182.30 1.82300 EACH 2017-11-15 - 2022-09-29 FSS
RIFAMPIN 600MG/VIL INJ Fresenius Kabi USA, LLC 63323-0351-20 20ML 130.69 6.53450 ML 2017-09-30 - 2022-09-29 FSS
RIFADIN 300MG CAP Sanofi Aventis U.S. LLC 00068-0508-60 60 272.41 4.54017 EACH 2019-10-15 - 2022-09-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.